Why Eastman Chemical (EMN) is on investors’ radar
Eastman Chemical (EMN) has drawn fresh attention after its recent share performance, with the stock showing mixed shorter term returns and a stronger move in the past 3 months.
See our latest analysis for Eastman Chemical.
At a share price of US$75.51, Eastman Chemical’s 30 day share price return of 8.93% and 90 day share price return of 21.89% contrast with a 1 year total shareholder return decline of 19.26%. This suggests recent momentum following weaker longer term results.
If you are reassessing materials exposure after Eastman Chemical’s recent move, it could be a moment to scan our screener of 8 top copper producer stocks for potential ideas.
The stock currently trades close to analyst targets yet sits at a sizeable modeled intrinsic discount, which raises the real question for you: Is Eastman Chemical still undervalued, or is the market already pricing in future growth?
Most Popular Narrative: 3% Overvalued
The most followed valuation narrative puts Eastman Chemical’s fair value at $73.35, slightly below the last close of $75.51, which sets up a tight valuation debate.
Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end-market demand recovers and utilization rates normalize.
Want to see what is really doing the heavy lifting in that fair value? Revenue staying steady, profits edging higher, and a future earnings multiple that assumes discipline sticks. Curious how those ingredients combine to support that price?
Result: Fair Value of $73.35 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can change quickly if trade tensions escalate or if demand in core end markets like autos and construction remains weaker for longer than expected.
Find out about the key risks to this Eastman Chemical narrative.
Another Take: Market Multiple Sends A Different Signal
The popular narrative says Eastman Chemical looks about 3% overvalued versus a fair value of $73.35, but the market’s own P/E tells a different story. At 18.2x earnings, the stock trades well below both peers at 32.6x and a fair ratio of 25.8x, which points to a sizeable valuation gap. Is that gap justified by slower growth and recent margin pressure, or does it hint at room for sentiment to shift?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Feeling that the story so far is only part of the picture? Act while the data is fresh, weigh both sides, and check out the 3 key rewards and 3 important warning signs before you decide.
Looking for more investment ideas?
If Eastman Chemical has sharpened your focus, do not stop here. Use these tailored screens to spot other opportunities that could fit your approach before the crowd does.
- Target quality at a discount by scanning our list of 46 high quality undervalued stocks that combine fundamentals with prices that may not fully reflect them yet.
- Prioritise resilience by checking the solid balance sheet and fundamentals stocks screener (39 results) that can help you focus on companies with financial structures built to handle tougher conditions.
- Get ahead of the herd by reviewing a screener containing 24 high quality undiscovered gems that highlights lesser known names with underlying strengths many investors might be overlooking.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com